uniQure Inc.: uniQure to Participate in Multiple Upcoming Industry Conferences in June
~ uniQure to host virtual Research & Development Day on June 22, 2021 ~
LEXINGTON, Mass. and AMSTERDAM, June 02, 2021(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences:
Jefferies Virtual Healthcare Conference, June 1 - 4, 2021
Members of uniQure s management team will participate in virtual one-on-one investor meetings throughout the day on Wednesday, June 2.
A fireside chat with Matt Kapusta (http://uniqure.com/about/management-team-matt-kapusta.php), chief executive officer, will take place the same day from 8:30 to 8:55 a.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investors & Newsroom (http://uniqure.com/investors-newsroom/events-presentations.php) section of the uniQ
~ uniQure to host virtual Research & Development Day on June 22, 2021 ~LEXINGTON, Mass. and AMSTERDAM, June 02, 2021(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for
uniQure to Participate in Multiple Upcoming Industry Conferences in June forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
uniQure Announces First Quarter 2021 Financial Results and Highlights Recent Company Progress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Zealand Pharma to Host R&D Day on March 5, 2021
Company announcement – No. 5 / 2021
Zealand Pharma March 5, 2021
Zealand Pharma’s virtual Research & Development Day on March 5, 2021 will highlight progress across R&D pipeline and five-year strategy.
Copenhagen, DK and Boston, MA, U.S. February 4, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced that it will host its virtual R&D Day for analysts and investors with a live Q&A session at 4:00 p.m. CET (10:00 a.m. ET) on Friday, March 5.
Zealand will discuss progress across its development pipeline and present the five-year R&D strategy during a prerecorded session that will become available to the public on March 4th, 24 hours before the live Q&A session on March 5th.